Raj Amin, MD
Adult Reconstructive Orthopaedic Surgery · Clovis, CANPI 1942689393
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,325 of the $53,097 with a category attached, or 60.9%. Think Surgical, Inc. accounts for 68.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $21,015 and has fallen 70.5% since, to $6,198 in 2025.
Across 103 payments — averaging $515.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Think Surgical, Inc.$36K
- Smith+Nephew$10K
- Stryker$5K
- Zimmer Biomet$738
- Cornerstone Medical Associates, Inc.$545
- Arthrex$276
- plus $515 from 9 others
What the payments were for
- Consulting fees$32,32561%
- Travel & lodging$6,08611%
- Food & beverage$4,6869%
- Education$10,00019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Think Surgical, Inc. | 21 | $36,332 |
| Smith+Nephew | 2 | $10,000 |
| Stryker | 46 | $4,692 |
| Zimmer Biomet | 9 | $738 |
| Cornerstone Medical Associates, Inc. | 3 | $545 |
| Arthrex | 5 | $276 |
| Johnson & Johnson(2 entities) | 3 | $206 |
| Vertex | 4 | $94 |
| Pacira Pharmaceuticals Incorporated | 2 | $47 |
| Davol Inc. | 2 | $43 |
| Avanos Medical | 2 | $33 |
| Solventum Corporation | 1 | $30 |
| Amgen | 1 | $28 |
| Bioventus LLC | 1 | $19 |
| Heraeus Medical, LLC. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TMINI Miniature Robotic System$32,863
- MAKO$3,601
- Tsolution One Surgical System$3,432
- ROSA-Knee$388
- Persona$103
- Proxilock Continuum Hips$103
- Avenir$103
- Taperloc$103
How this compares
$53,097 in reported general payments places this provider in the 75th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $8,356 |
| Oxycodone Hcl | 121 | $772 |
| Naproxen | 77 | $537 |
| Clindamycin Hcl | 42 | $426 |
| Cephalexin | 46 | $319 |
| Doxycycline Monohydrate | 15 | $163 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $114 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Clovis
- Arbi NazarianClovis$155K
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
- Thomas DonaldsonColton$893K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.